Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs.

Rivera N, Ramnanan CJ, An Z, Farmer T, Smith M, Farmer B, Irimia JM, Snead W, Lautz M, Roach PJ, Cherrington AD.

J Clin Invest. 2010 Dec;120(12):4425-35. doi: 10.1172/JCI40919. Epub 2010 Nov 15.

2.

The role of glucagon in the regulation of plasma lipids.

Schade DS, Woodside W, Eaton RP.

Metabolism. 1979 Aug;28(8):874-86. Review.

PMID:
378241
3.

Control of hepatic glucose output by glucagon and insulin in the intact dog.

Cherrington AD, Chiasson JL, Liljenquist JE, Lacy WW, Park CR.

Biochem Soc Symp. 1978;(43):31-45. Review.

PMID:
373768
4.
5.

Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon.

Chung ST, Haymond MW.

J Diabetes Sci Technol. 2015 Jan;9(1):44-51. doi: 10.1177/1932296814547518. Epub 2014 Aug 26. Review.

6.

Hypoglycemia unawareness prevention: Targeting glucagon production.

Samson WK, Stein LM, Elrick M, Salvatori A, Kolar G, Corbett JA, Yosten GL.

Physiol Behav. 2016 Aug 1;162:147-50. doi: 10.1016/j.physbeh.2016.04.012. Epub 2016 Apr 11. Review.

7.

Exercise and the Regulation of Hepatic Metabolism.

Trefts E, Williams AS, Wasserman DH.

Prog Mol Biol Transl Sci. 2015;135:203-25. doi: 10.1016/bs.pmbts.2015.07.010. Epub 2015 Aug 5. Review.

8.

Gut-derived proteolysis during insulin-induced hypoglycemia: the pain that breaks down the gut.

Molina PE, Abumrad NN.

JPEN J Parenter Enteral Nutr. 1994 Nov-Dec;18(6):549-56. Review.

PMID:
7602732
9.

A Transdermal Glucagon Patch for Severe Hypoglycemia.

Palylyk-Colwell E, Ford C.

CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016-. 159.

Supplemental Content

Support Center